PHARMA
Nestlé Establishes Research Center in Singapore
The Center will focus on healthy aging and nutritional interventions for older populations, both regionally and globally.
India’s Sun Pharma Acquires Novartis Prescription Brands In Japan
Sun Pharma has made strategic moves into the Japanese market by buying 14 established prescription brands from Novartis Japan.
Japanese Fund Invests In The Eradication Of Malaria & TB
GHIT Fund, a public-private partnership that seeks to nurture Japan's R&D, has invested in a malaria vaccine and rapid field test.
WuXi AppTec Expands To South Korea
China-based WuXi Apptec, an R&D capability and technology company, has opened an office in Seoul's Pangyo Techno Valley.
Huawei and WuXi AppTec Collaborate On Precision Medicine Cloud Platform
This strategic alliance will put a population genomics system on the cloud to support the delivery of China’s Precision Medicine Initiative.
Cipla Strengthens Presence In US Market
The UK arm of India-based pharmaceutical Cipla has acquired two US-based companies to further their reach in that region.
US$50 Million VC Fund To Focus On Singaporean Life Sciences
Lightstone Singapore has closed a US$50 million funding round backed by Singapore's EDBI and Temasek Holdings.
Dangdai Invests Over US$43 Million In CBMG
Dangdai's investment in CMBG will help further long-term clinical trials for stem cell therapies and chimeric antigen receptor T-cell trials for selected cancers.
WuXi AppTec To Build Biologics Solution Center
WuXi's Shanghai-based center, which will be operational by 2017, will provide integrated solutions for biologics discovery, development and clinical manufacturing.
